ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2015
Factors associated with long-term survival in dogs undergoing liver lobectomy as treatment for liver tumors.
Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 34 citations in OpenAlex.
- Prognosis and associated risk factors after conservative management of dogs with liver tumors.Journal of veterinary internal medicine · 2026Article
- Primary Hepatic Masses in Ten Dogs: A Retrospective Surgical Case Series.Veterinary sciences · 2026Article
- Utility of intraoperative 3-dimensional C-arm cone-beam computed tomography for hepatic transarterial chemoembolization.Frontiers in veterinary science · 2026Article
- Lymphopenia predicts reduced survival in canine hepatocellular carcinoma.Journal of veterinary science · 2023Article
- Investigating a Prognostic Factor for Canine Hepatocellular Carcinoma: Analysis of Different Histological Grading Systems and the Role of PIVKA-II.Veterinary sciences · 2022Article
- Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs.Veterinary sciences · 2022Review
- Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case-control study.Veterinary and comparative oncology · 2022Article
- Effect of drug-eluting bead transarterial chemoembolization loaded with cisplatin on normal dogs.The Journal of veterinary medical science · 2022Article
- Drug-eluting bead chemoembolization for the treatment of nonresectable hepatic carcinoma in dogs: A prospective clinical trial.Journal of veterinary internal medicine · 2021Article
- Quantitative ultrasound elastography and serum ferritin level in dogs with liver tumors.Journal of advanced veterinary and animal research · 2020Article
- Size of canine hepatocellular carcinoma as an adverse prognostic factor for surgery.Journal of advanced veterinary and animal research · 2020Article
- Influence of hepatic neoplasia on life expectancy in dogs.Veterinary world · 2020Article
- Therapeutic response and prognostic factors of 14 dogs undergoing transcatheter arterial embolization for hepatocellular masses: A retrospective study.Journal of veterinary internal medicineArticle
- Hepatic Dearterialization for Nonresectable Liver Tumors in Five Dogs and Two Cats.Journal of veterinary internal medicineArticle
- Factors associated with survival in dogs with a histopathological diagnosis of hepatocellular carcinoma: 94 cases (2007-2018).Open veterinary journalArticle
- Laparoscopic liver lobectomy in a cat.JFMS open reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objectives of the study were to describe clinicopathologic findings in dogs that underwent surgical treatment of liver tumors and to define outcome-associated variables in this canine population. Medical records of 118 dogs that underwent liver lobectomy were reviewed. Variables were assessed via univariate and multivariate Cox regression analyses. Hazard ratios, median survival times (MSTs), and Kaplan-Meier Survival curves (KMSCs) were created for significant variables. Of the dogs with surgically addressed hepatic tumors, 93% survived to discharge. The MST was not reached. Lethargic dogs had a mortality risk 10.2 times that of non-lethargic dogs. Non-tachypneic dogs had a mortality risk 4.3 times that of tachypneic dogs. Dogs that experienced anesthetic complications had a mortality risk 100 times that of dogs that did not. We conclude that the prognosis associated with liver tumors is good. Lethargy, respiratory rate, and anesthetic complications were associated with outcome.
Indexed as
Identifiers
26028682PMC4431158W639226182What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.